Investor Growth Capital Europe is a committed investor with a long-term investment philosophy, staying power and value-creating agendas. We always work closely with the management of our holdings to develop their growth strategy, business and organization.

Our holdings directly benefit from the experience and analytical skills of our investment professionals and the technical and managerial expertise of our senior advisers. Today, we primarily invest in expansion-stage companies in the life sciences and technology fields.

Investment criteria

Our investment horizon is normally between three and seven years, with investments initially ranging between EUR 3 and 20 million. Follow-on investments are made as appropriate. We prefer to invest in companies with innovative technologies and products, and with a scalable business model offering a sustainable competitive advantage.

Investor Growth Capital Europe Investment candidates typically have proven market potential and some level of established customer base or clinical evidence. They are driven by strong and highly motivated management teams working in strategic partnership with us.

Investment sectors

We invest in companies and technologies that have successfully passed their first stages of development. Our investment candidates are typically found within the following subsectors:

Life Sciences

• Medical devices
• Pharmaceuticals and bioceuticals
• Diagnostics
• Healthcare services and life science tools

Technology

• Software
• Telecom and datacom equipment
• Nanotechnology and materials
• Clean technologies